Free Trial

Enlivex Therapeutics (ENLV) Institutional Ownership

→ My top 100 stocks… (From DTI) (Ad)
Free ENLV Stock Alerts
$1.44
-0.01 (-0.69%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Enlivex Therapeutics (NASDAQ:ENLV)

Current
Institutional Ownership
Percentage
1.02%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$54.60K
Number of
Institutional Sellers
(last 12 months)
0
Get ENLV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enlivex Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ENLV Institutional Buying and Selling by Quarter

Enlivex Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/1/2023Compagnie Lombard Odier SCmA65,000$225K0.0%+30.0%0.350%
2/9/2023Group One Trading L.P.13,499$53K0.0%+2,689.0%0.073%
7/11/2022 ARK Investment Management LLC331,001$1.66M0.0%-23.8%1.802%
4/27/2022Compagnie Lombard Odier SCmA50,000$279K0.0%+16.3%0.273%
4/20/2022Belvedere Trading LLC14,473$101K0.0%-13.9%0.079%
4/19/2022 ARK Investment Management LLC434,343$2.43M0.0%+24.3%2.372%
2/9/2022Compagnie Lombard Odier SCmA43,000$247K0.0%+22.9%0.235%
2/3/2022ACT Capital Management LLC25,000$156K0.1%-69.7%0.137%
1/28/2022 ARK Investment Management LLC349,308$2.18M0.0%-23.7%1.908%
1/21/2022Golden Green Inc.19,967$125K0.1%-54.7%0.109%
11/12/2021Renaissance Technologies LLC87,989$869K0.0%-55.0%0.481%
10/28/2021Compagnie Lombard Odier SCmA35,000$353K0.0%+40.0%0.191%
10/8/2021Golden Green Inc.44,085$436K0.3%-4.2%0.241%
8/13/2021Renaissance Technologies LLC195,706$1.74M0.0%-32.6%1.242%
8/11/2021 Banque Cantonale Vaudoise10,000$89K0.0%N/A0.063%
8/5/2021 ARK Investment Management LLC514,807$4.58M0.0%+8.1%3.267%
7/17/2021Golden Green Inc.46,020$410K0.3%-34.1%0.292%
5/18/2021Jane Street Group LLC11,070$123K0.0%N/A0.070%
5/17/2021Edmond DE Rothschild Holding S.A.13,000$144K0.0%N/A0.082%
5/17/2021Goldman Sachs Group Inc.12,986$144K0.0%N/A0.082%
5/13/2021 ARK Investment Management LLC476,414$5.28M0.0%N/A3.023%
5/13/2021Renaissance Technologies LLC290,406$3.22M0.0%+4.0%1.843%
5/12/2021UBS Group AG10,872$120K0.0%-51.5%0.069%
4/23/2021Compagnie Lombard Odier SCmA25,000$267K0.0%N/A0.159%
4/13/2021Golden Green Inc.69,782$774K0.7%+51.5%0.443%
2/10/2021Renaissance Technologies LLC279,106$2.35M0.0%-6.5%2.073%
1/25/2021Golden Green Inc.46,056$388K0.4%N/A0.342%
11/17/2020Jane Street Group LLC10,807$64K0.0%-64.8%0.080%
9/15/2020Two Sigma Advisers LP10,100$51K0.0%N/A0.075%
8/17/2020Jane Street Group LLC30,711$155K0.0%N/A0.229%
8/14/2020Sabby Management LLC12,925$65K0.0%-97.1%0.096%
5/15/2020Sabby Management LLC445,673$2.09M0.9%N/A3.319%
5/15/2020Morgan Stanley28,149$132K0.0%+1,407,350.0%0.210%
(Data available from 1/1/2016 forward)

ENLV Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ENLV shares?

During the previous two years, the following institutional investors and hedge funds held shares of Enlivex Therapeutics shares: ARK Investment Management LLC ($1.66M), and Compagnie Lombard Odier SCmA ($225K), Group One Trading L.P. ($53K).Learn more on ENLV's institutional investors.

What percentage of Enlivex Therapeutics stock is owned by institutional investors?

1.02% of Enlivex Therapeutics stock is owned by institutional investors. Learn more on ENLV's institutional investor holdings.

Which institutional investors have been buying Enlivex Therapeutics stock?

The following institutional investors have purchased Enlivex Therapeutics stock in the last 24 months: Compagnie Lombard Odier SCmA ($22K), and Group One Trading L.P. ($13.02K).

How much institutional buying is happening at Enlivex Therapeutics?

Institutional investors have bought a total of 35,015 shares in the last 24 months. This purchase volume represents approximately $144.98K in transactions.

Which Enlivex Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Enlivex Therapeutics stock in the last 24 months: ARK Investment Management LLC ($103.34K).

How much institutional selling is happening at Enlivex Therapeutics?

Institutional investors have sold a total of 103,342 shares in the last 24 months. This volume of shares sold represents approximately $467.11K in transactions.


Related Companies:
This page (NASDAQ:ENLV) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
These AI trades triggered this morning (545% return)
Prosper Trading Academy
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
He Is Giving Away Bitcoin
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Fed launches fourth dollar overhaul
Stansberry Research
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders
A.I. is a Tidal Wave - Here’s What to Buy
Chaikin Analytics